Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Phenotype C0023895|liver disease
Sentences 177
PubMedID- 22448309 Reported four adults being assessed for liver transplantation because of chronic liver diseases (three with cryptogenic hepatitis and one with congenital hepatic fibrosis) in whom cd was diagnosed following serological screening and gluten withdrawal led to improvement of hepatic function, eliminating the need for liver transplantation.
PubMedID- 26125137 Low cross-neutralization of hepatitis c correlates with liver disease in immunocompromized patients.
PubMedID- 22087124 Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis c treated with alpha-interferon and ribavirin: rosuvastatin reduces nafld in hcv patients.
PubMedID- 21128862 liver disease in patients with chronic hepatitis c virus (hcv) infection has an accelerated course in the presence of human immunodeficiency virus (hiv) coinfection.
PubMedID- 22797645 Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy: a randomized controlled trial.
PubMedID- 19800334 Background & aims: human immunodeficiency virus (hiv) infection accelerates liver disease progression in patients with hepatitis c virus (hcv) and could shorten survival of those awaiting liver transplants.
PubMedID- 21911884 Conclusion: based on our data, microsatellite variations in the hmox1 and ugt1a1 genes are not likely to protect from progression of liver disease in patients with chronic hepatitis c.
PubMedID- 23633957 These observations support a model of hepatic inflammation induced by phagocytic uptake of hcv by resident macrophages/kupffer cells to trigger il-1β and drive expression of proinflammatory cytokines, with il-1β expression associating with liver disease in patients with chronic hepatitis c infection (figure.
PubMedID- 23061403 In high income settings, chronic liver disease – associated with hepatitis c and b virus, long term drug-induced toxicity, alcohol related and non-alcoholic fatty liver disease – has become a leading cause of chronic morbidity and mortality in people living with hiv [14].
PubMedID- 23497336 Eltrombopag, an oral, nonpeptide, thrombopoietin receptor agonist, increases platelet counts in adult patients with chronic immune thrombocytopenia (itp) [15-19] and chronic liver disease due to hepatitis c virus infection [20,21].
PubMedID- 25663852 In the majority of cases, hcc originates from chronic liver diseases, mainly with progression from hepatitis b virus (hbv) and hepatitis c virus (hcv) to cirrhosis in asian populations.
PubMedID- 20334631 Site-specific k18 hyperphosphorylation was shown to strongly correlate with the progression of liver diseases in patients with chronic noncirrhotic hepatitis c virus (hcv) [17].
PubMedID- 23827008 In many countries, the burden of chronic liver disease due to hepatitis b and c is increasing due to ageing of unvaccinated populations and migration, and a probable increase in drug injecting.
PubMedID- 21294867 The high proportion of patients with chronic liver disease associated with hepatitis c virus coinfection might have contributed to lessen the differences between treatment groups.
PubMedID- 21191876 [low response rate to a vaccination against hepatitis b in patients with end-stage liver disease].
PubMedID- 23722669 Patients with hcv infection at presentation were included, but patients with complications such as underlying lymphoproliferative disorders, autoimmune diseases like lupus nephritis, infection, and liver disease due to hepatitis b virus or alcohol abuse were excluded.
PubMedID- 23763386 Aim: in chronic liver disease associated with hepatitis c virus (hcv), a low platelet count is a major obstacle in carrying out interferon (ifn) treatment.
PubMedID- 25578311 Platelets are key elements in the pathogenesis of acute and chronic liver disease associated with hepatitis b virus (hbv) infection by promoting the accumulation of virus-specific cd8(+) t cells and nonspecific inflammatory cells into the liver parenchyma.
PubMedID- 22141390 Entecavir: a review of its use in the treatment of chronic hepatitis b in patients with decompensated liver disease.
PubMedID- 21057160 Twenty-one patients (62%) had liver disease associated with hepatitis c virus (hcv) and 5 patients with hepatitis b virus (62%).
PubMedID- 26357604 Especially noticeable is the rapid decline by 47% from 1999 to 2006 of incidence rate of waiting list registration for end stage liver disease due to hepatitis b compared to that due to hepatitis c or non-viral liver disease.46 the temporal correlation of the trend and the availability of anti-hbv nucleos(t)ides, starting with use of lam in 1998, suggests that broad application of these medications, in part, contributed to the decreased incidence of decompensated chb disease.
PubMedID- 21055694 Morphologic aspects of liver disease associated with hepatitis b and c viruses, autoimmune hepatitis, and hiv infection were addressed, as was the prevalent problem of nonalcoholic fatty liver disease.
PubMedID- 23626552 In older patients, common predisposing conditions include cirrhosis in general, and in particular chronic liver disease associated with persistent hepatitis b and c infection.
PubMedID- 20424599 For hb, achieving safe, effective gene transfer in skeletal muscle would afford a therapeutic alternative to those patients with advanced liver disease due to hepatitis c contracted from plasma-derived coagulation concentrates.
PubMedID- 20154579 Introduction: since the advent of haart, liver-related mortality has become the leading cause of non-aids deaths in hiv-infected patients in western countries, complications of end-stage liver disease due to chronic hepatitis b, chronic hepatitis c or both being mainly responsible.
PubMedID- 21331379 Tlr-mediated signals result in liver disease associated with hepatitis b, hepatitis c, alcoholicnonalcoholic steatohepatitis, and hepatic fibrosis [19].
PubMedID- 20388084 Most cases of hcc develop on a pre-existing chronic liver disease, usually due to hepatitis c virus (hcv), hepatitis b virus (hbv), or alcohol.
PubMedID- 25131040 The population had an average age of 57.5 years, predominantly formed by men (82.5%), with an average imc of 26.7, meld of 13, with viral hepatitis as main cause of liver disease.
PubMedID- 21167429 Severe forms of hepatitis are associated with underlying chronic liver disease such alcoholic disease.
PubMedID- 22084743 A 66-year-old man with chronic liver disease due to hepatitis b developed hepatocellular carcinoma for which a right partial hepatectomy was performed.
PubMedID- 21743223 She was suffering from end-stage liver disease due to hepatitis c virus (hcv) infection and renal disease due to diabetic nephropathy.
PubMedID- 24695489 End stage liver disease associated with hepatitis c virus infection constitutes one of the principal indications for liver transplant.
PubMedID- 19330428 Objective: the aim of this study was to establish standardization of modes of pt reporting by the interchangeability analysis of prothrombin time in patients with advanced liver disease associated with viral hepatitis measured with different thromboplastin reagents by the use of various methods of expression, i.e.
PubMedID- 21031537 Liver transplantation is currently the only definitive modality for the treatment of end-stage liver disease due to chronic hepatitis c.
PubMedID- 22856889 The misconception that severe liver disease due to hepatitis b would show symptoms may contribute to unwillingness of patients to take time to attend regular medical follow up[21], and this would cause deterioration of the disease condition if treatment is delayed.
PubMedID- 22172892 A 43-year-old man with end-stage liver disease due to hepatitis c and b virus infections and alcoholic cirrhosis received a liver transplantation under immunosuppressive treatment with tacrolimus and mycophenolate mofetil.
PubMedID- 26294919 Initial findings revealed that human bm-mscs were able to improve liver function in hepatitis b patients with end-stage liver disease [45].
PubMedID- 24693307 Non-invasive histologic markers of liver disease in patients with chronic hepatitis b.
PubMedID- 24768454 The leading causes of chronic liver disease associated with hcc are hepatitis b and c viruses throughout the world, and alcohol and nash in france.
PubMedID- 25266850 Additionally, test and treat is recommended for selected groups of hiv-positive individuals, namely, (a) people with tuberculosis in 58 countries, (b) pregnant women in 42 countries, (c) people with liver disease due to hepatitis b co-infection in 52 countries, (d) serodiscordant couples in 35 countries and (e) children below 5 years in nine countries.
PubMedID- 21040191 Two of these 47 infants had liver disease; one was diagnosed with neonatal hepatitis syndrome, and the other was diagnosed with ba.
PubMedID- 24651854 Importantly, similar m2-like macrophage accumulation was confirmed in chronic hepatitis b patients with liver diseases.
PubMedID- 25596623 Additionally, risk factors such as heavy alcohol use or co-infection with hepatitis b may lead to progression of liver disease even in the presence of svr.
PubMedID- 20386865 The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis c virus (hcv) are not well understood.
PubMedID- 24152445 After stratification of our cohort, the association between the srebp1c variant and liver stiffness was replicated in the sub-cohort of patients with viral hepatitis, but not in patients with non-viral liver disease.
PubMedID- 19902246 Antiviral therapy of chronic hepatitis c in patients with advanced liver disease and after liver transplantation.
PubMedID- 23801844 Aim: to evaluate psychometrics of the chinese (mainland) chronic liver disease questionnaire (cldq) in patients with chronic hepatitis b (chb).
PubMedID- 22434987 Background: since the introduction of highly active anti-retroviral therapy and the dramatic improvement in the prognosis of individuals with human immunodeficiency virus, liver disease due to chronic viral hepatitis has become as important cause of morbidity and mortality in co-infected individuals.
PubMedID- 22542039 liver disease due to chronic hepatitis c is now a leading cause of mortality among hiv-infected patients in the developed world.
PubMedID- 21343496 Objective: the purpose of our study was to compare the utility of mr elastography (mre) and diffusion-weighted imaging (dwi) in characterizing fibrosis and chronic hepatitis in patients with chronic liver diseases.

Page: 1 2 3 4